Recovery
BPC-157 & TB-500 Dual-Action Angiogenic & Tissue Research Blend
Recovery
BPC-157 & TB-500 research overview
- CAS Number
- 137525-51-0 / 77591-33-4
- Molecular Formula
- BPC-157 (C₆₂H₉₈N₁₆O₂₂) + TB-500 fragment
- HPLC Purity
- ≥99% (batch-verified)
- Form
- Lyophilised powder
- Storage
- 2–8°C, desiccated, protected from light
- Classification
- Research reagent - in vitro use only
A single vial containing 10mg of BPC-157 and 10mg of TB-500 - two of the most widely studied tissue-repair peptides in preclinical research. Combining them in one vial means researchers only need to reconstitute (dissolve and prepare) the compound once to work with both together.
The BPC-157 & TB-500 combination vial from Velox Peptides contains both peptides co-lyophilised in a single sterile vial — a convenient format for research protocols that incorporate both compounds simultaneously. BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic pentadecapeptide studied in the context of angiogenesis, tendon and ligament repair, gastrointestinal mucosal protection, and VEGF signalling. TB-500 is a synthetic peptide fragment of Thymosin Beta-4 (Tβ4), studied for its role in actin-mediated cell motility, tissue repair, and new blood vessel formation. Together, they represent two of the most widely studied repair-associated peptides in preclinical research.
The rationale for combining BPC-157 and TB-500 in preclinical research derives from their complementary mechanisms. BPC-157’s effects have been primarily studied through its interaction with growth hormone receptor expression and vascular endothelial growth factor (VEGF) pathways — promoting angiogenic and tissue growth signals in rodent wound and tendon models. TB-500’s core mechanism centres on the LKKTET actin-binding sequence of Thymosin Beta-4, which sequesters G-actin monomers and promotes the directed cell motility necessary for wound closure. Studies combining both peptides in rodent models have examined whether their distinct mechanistic profiles produce additive or synergistic effects on tissue repair endpoints.
The combination vial contains each compound at its individual research-grade specification: BPC-157 at ≥99.4% HPLC purity and TB-500 at ≥99% HPLC purity, co-lyophilised in defined proportions. Batch documentation is available on request. Researchers requiring independent dosing of each compound should order BPC-157 and TB-500 individually — both are available separately in the Healing & Repair category. Not for human or veterinary consumption.
Summary paraphrased from the peer-reviewed preclinical literature. For in vitro research use only. For source citations, email support@veloxpeps.com.
BPC-157 / TB-500 Research Hub
Technical data
Compound specifications
| Common name | BPC-157 & TB-500 |
|---|---|
| Full name | Dual-Action Angiogenic & Tissue Research Blend |
| CAS number | 137525-51-0 / 77591-33-4 |
| Molecular formula | BPC-157 (C₆₂H₉₈N₁₆O₂₂) + TB-500 fragment |
| Molecular weight | 1419.5 + 4963.4 g/mol |
| Sequence | GEPPPGKPADDAGLV (BPC-157) + Ac-SD...Ac-SDKPDMAEIEKFDKS-fragment (TB-500) |
| HPLC purity | ≥99% (batch-verified) |
| Appearance | White to off-white lyophilised powder |
| Solubility | Bacteriostatic water, sterile saline |
| Storage (lyophilised) | 2–8°C, protected from light |
| Storage (reconstituted) | 2–8°C, up to 28 days |
| Supplied as | 20mg (10mg BPC-157 + 10mg TB-500) |
Purity & documentation
Batch testing and certificate of analysis
Every batch of BPC-157 & TB-500 is third-party HPLC-tested prior to dispatch. Batch documentation is available on request.
Previous batch CoAs are archived in the CoA library. For batch-specific CoA requests prior to purchase, contact support@veloxpeps.com.
Delivery & payment
Buying BPC-157 & TB-500 in the UK
BPC-157 & TB-500 is sold by Velox Peptides (CRP Labs Ltd, UK company no. NI738125) and dispatched from the UK. Choose a vial size, pay on one page, and your order is dispatched the next working day.
- Delivery: Royal Mail Tracked 24 (1–2 working days, £5.99, free over £100) or Tracked 48 (2–3 working days, £3.80). See shipping.
- Payment: Pay by Bank through FCA-authorised open banking, or bank transfer. No card details needed.
- Testing: See the batch testing details above and past reports in the CoA library.
- Research use only: Supplied as a research reagent for in vitro use. Not for human or veterinary consumption. See our Research Use Policy.
Explore more research compounds:
No account needed
How to order
No card details required - Pay by Bank or manual bank transfer
Add to order & proceed to checkout
We email you bank details instantly
Transfer & we dispatch next working day
What is in the BPC-157 & TB-500 vial?
What purity is the BPC-157 & TB-500?
How is the BPC-157 & TB-500 reconstituted for research use?
What is the difference between the BPC-157 & TB-500 and the BPC-157 + TB-500 Bundle?
Is BPC-157 & TB-500 legal to buy in the UK?
How does the combination vial differ from ordering BPC-157 and TB-500 separately?
How quickly is my order dispatched and delivered?
How do I pay, and is it secure?
Does my order include a certificate of analysis?
Compliance notice
For in vitro research use only. BPC-157 & TB-500 is supplied solely as a research reagent for qualified professionals conducting in vitro or animal-model studies. It is not a medicinal product within the meaning of the Human Medicines Regulations 2012. It has not been evaluated by the MHRA or FDA. It is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale.
Research bulletin
Free Researcher’s Handbook + 10% off
New compound arrivals, batch-release notices and plain-language research summaries, plus our reconstitution, storage & CoA handbook (PDF) and a 10% off code for your first research order.
For researchers only. Unsubscribe at any time. We never share your address.
